Glucose metabolism in the rat frontal cortex recovered without the recovery of choline acetyltransferase activity after lesioning of the nucleus basalis magnocellularis. 2000

Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
Department of Neurology, Graduate School of Medicine, Kyoto University, Japan.

We measured the cerebral metabolic rate of glucose (CMRglc) by using positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) and the choline acetyltransferase (ChAT) activity at 3 days and 3 months after destruction of the nucleus basalis magnocellularis (NBM). Although the frontal ChAT activity remained 20% lower than that of controls even at 3 months post-lesioning, the frontal CMRglc, which was reduced by 40% at 3 days, returned to normal at 3 months, namely CMRglc recovered with time without the recovery of ChAT activity with time. Since glucose metabolism reflects mainly presynaptic neuronal activity, we speculate that presynaptic rearrangement may have some relation to the recovery of CMRglc.

UI MeSH Term Description Entries
D007051 Ibotenic Acid A neurotoxic isoxazole (similar to KAINIC ACID and MUSCIMOL) found in AMANITA mushrooms. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist. Acid, Ibotenic
D008297 Male Males
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002795 Choline O-Acetyltransferase An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6. Choline Acetylase,Choline Acetyltransferase,Acetylase, Choline,Acetyltransferase, Choline,Choline O Acetyltransferase,O-Acetyltransferase, Choline
D005625 Frontal Lobe The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus. Brodmann Area 8,Brodmann's Area 8,Frontal Cortex,Frontal Eye Fields,Lobus Frontalis,Supplementary Eye Field,Area 8, Brodmann,Area 8, Brodmann's,Brodmanns Area 8,Cortex, Frontal,Eye Field, Frontal,Eye Field, Supplementary,Eye Fields, Frontal,Frontal Cortices,Frontal Eye Field,Frontal Lobes,Lobe, Frontal,Supplementary Eye Fields
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
February 1988, Journal of neurochemistry,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
September 1988, Pharmacological research communications,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
July 1984, Brain research,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
December 1993, Brain research,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
December 1993, Neuroscience letters,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
January 1984, Experimental brain research,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
September 1997, The International journal of neuroscience,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
January 1992, Archives of gerontology and geriatrics,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
April 1987, Neuroscience research,
Y Katsumi, and T Hayashi, and C Oyanagi, and Y Nagahama, and H Yamauchi, and S Ono, and H Fukuyama, and H Shibasaki
November 2004, Journal of ethnopharmacology,
Copied contents to your clipboard!